In Brief: SmithKline Beecham
This article was originally published in The Tan Sheet
Executive Summary
SmithKline Beecham: "Don't expect us to make another big acquisition tomorrow," SB Chairman and CEO Jan Leschly told Alex. Brown May 17, as the company must make the necessary synergies with its 1994 buying spree. Last year, SmithKline acquired pharmacy benefit management firm DPS in May for $2.3 bil., bought Sterling Health for $2.9 bil. in August and divested Sterling Health North America in September for $1 bil. ("The Tan Sheet" Sept. 19, 1994, pp. 1-4). In November, SB sold its animal health business to Pfizer for $1.45 bil. SmithKline will continue investing in numerous small company collaborative ventures, Leschly noted. SmithKline has made 130 deals in the last three years with small or start-up companies, he noted...